首页|Targeting dysregulated splicing factors in cancer:lessons learned from RBM10 deficiency

Targeting dysregulated splicing factors in cancer:lessons learned from RBM10 deficiency

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据

Yongbo Wang、Zefeng Wang

展开 >

Minhang Hospital,Department of Cellular and Genetic Medicine,School of Basic Medical Sciences,Institutes of Biomedical Sciences,Fudan University,Shanghai 200032,China

CAS Key Laboratory of Computational Biology,Shanghai Institute of Nutrition and Health,Chinese Academy of Sciences,Shanghai 200031,China

National Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaShanghai Municipal Natural Science FundInnovation Research Team of Highlevel Local Universities in ShanghaiStrategic Priority Research Program of Chinese Academy of Sciences(CAS)National Key Research and Development Program of ChinaStarry Night Science Fund at Shanghai Institute for Advanced Study of Zhejiang UniversityCAS Interdisciplinary Innovation Team and the type A CAS Pioneer 100-Talent Program

81871878320300643173011020ZR1406500XDB380401002021YFA1300503SN-ZJU-SIAS-009

2023

10.1093/jmcb/mjad063

分子细胞生物学报(英文版)
中国科学院上海生命科学研究院,生物化学与细胞生物学研究所,中国细胞生物学学会

分子细胞生物学报(英文版)

CSTPCDCSCD
影响因子：0.595
ISSN：1673-520X
年,卷(期)：2023.(10)
  • 32